The Europe direct-to-consumer laboratory testing market is expected to grow from USD 980 million in 2025 to approximately USD 2.26 billion by 2035, at a CAGR of 8.70%. This growth is driven by increasing consumer interest in convenient, at- home diagnostic solutions and advancements in personalized healthcare technologies.

Europe Direct-To-Consumer Laboratory Testing Market Statical Scope

In Europe, the growth of the DTC laboratory testing market is fueled by several factors, including the rising incidence of chronic diseases and sexually transmitted infections, increased disposable income, growing consumer awareness about personal health management, and the convenience, affordability, and accessibility of DTC laboratory testing. The increasing prevalence of chronic and infectious diseases, escalating healthcare costs, heightened awareness about ancestry and genealogy testing, and an aging population contribute further to this growth.

Europe Direct-To-Consumer Laboratory Testing Market Share, By Product, 2025 (%)

• Medical genetic laboratory testing- Medical genetic laboratory testing dominates the market, with a share of 55%, driven by increasing demand for personalized medicine, preventive healthcare, and ancestry-based insights.
• Routine clinical laboratory testing- Routine clinical laboratory testing holds a significant share of 45% of the market, supported by the growing need for regular health monitoring.

Europe Direct-To-Consumer Laboratory Testing Market Share, By Test Type, 2025 (%)

• Genetic testing- Genetic testing leads the market with a share of 20%, driven by rising consumer interest in personalized health insights and early risk identification.
• Cancer testing- Cancer testing holds a strong share of 18% of the market, supported by increasing awareness and demand for early detection solutions.
• Routine testing- Routine testing accounts for 15% of the market, driven by demand for general health check-ups and ongoing monitoring.
• Diabetes testing- Diabetes testing represents 14% of the market, supported by the rising prevalence of diabetes and the need for regular screening.

Europe Direct-To-Consumer Laboratory Testing Market Share, By Sample Type, 2025 (%)

• Blood- Blood-based testing dominates the market, with a share of 45%, driven by its high accuracy and wide applicability across multiple test types.
• Saliva- Saliva-based testing holds a share of 25% of the market, supported by its non-invasive nature and growing use in genetic testing.
• Urine- Urine-based testing accounts for 20% of the market, driven by ease of collection and use in routine diagnostics.

Top Companies in the Europe Direct-To-Consumer Laboratory Testing Market

• Any Lab Test Now, Inc.
• Color Genomics, Inc
• Counsyl, Inc.
• DanteLabs Inc.
• Direct Laboratory Services, LLC
• Eastern Biotech & Life Sciences
• EasyDNA
• EverlyWell, Inc.,
• Full Genomes Corporation, Inc.
• Gene by Gene, Ltd.
• Genecodebook Oy
• Genesis Healthcare Co.
• Genetrainer
• GHC Genetics UK
• HealthCheckUSA
• Home Access Health Corporation
• International Biosciences
• Laboratory Corporation of America Holdings
• LetsGetChecked, Inc.
• Mapmygenome India Limited

Segments Covered in the Report

By Product

• Medical Genetic Laboratory Testing
• Routine Clinical Laboratory Testing

By Test Type

• Genetic Testing
• Cancer
• Diabetes Testing
• Disease Risk Assessment Testing
• COVID-19
• Sexually Transmitted Disease Testing
• Routine Testing

By Sample Type

• Blood
• Urine
• Saliva
• Others